« Back
Home /
SB242235

SB242235

Item no.	TMO-T4078-2mg
Manufacturer	TargetMol
CASRN	193746-75-7
Amount	2mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,9914
Citations	1.Badger, A.M., et al., Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage, 2000. 8(6): p. 434-43.
Smiles	COc1nccc(n1)c1c(ncn1C1CCNCC1)c1ccc(cc1)F
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	p38 MAPK inhibitor, SB-242235 , SB242235
Available
Short Description	SB 242235 is a potent and selective p38 MAP kinase inhibitor that may be an effective therapy for cytokine-mediated diseases.
Shipping	cool pack
Storage	-20°
Target names or alias	SB-242235 , SB242235
Molecular Weight	353, 39
Pathway	MAPK\|\|\|Autophagy
Target	Autophagy\|\|\|p38 MAPK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 2mg

available

Delivery expected until 9/27/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail